Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, Celebration FL, Sioux Falls SD,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06803680

Phase 1, Recruiting

Comprehensive Care for AYA: Needs Assessment Survey

for
Cancer, Young Adult Cancer, Adolescent Cancer
Location: Winston-Salem NC, Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 15+

Code: NCT07196241

Recruiting

A Study of Live Tumor Fragments of Surgical Resections

for
Cancer, Tumor
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07000864

Recruiting

Immune Reconstitution in Stem Cell Transplant Recipients

for
Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18 - 70+

Code: NCT02129543

Recruiting

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

for
Oncology, Myeloid Leukemia, Acute, Cancer
Location: Rochester NY, Chapel Hill NC, Winston-Salem NC,
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT06697600

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

for
Advanced Solid Tumors, Hematologic Malignancies
Location: Canton OH, Detroit MI, Chicago IL
Sponsor: Acrotech Biopharma Inc.

Sex: All

Age: 18+

Code: NCT07036133

Phase 1, Recruiting

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06880861

Recruiting

New Assessment System in Measuring Symptom Distress in Cancer Patients

for
Caregiver, Health Care Provider, Malignant Neoplasm, Physician
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00505245

Recruiting

Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 0+

Code: NCT06314672

Recruiting

A Natural History Study of Metabolic Sizing in Health and Disease

for
Metabolic Disorders, Cancer, Chronic Kidney Disease, Diabetes,
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 2 - 70+

Code: NCT05398783

Recruiting

A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

for
Advanced Stage Solid Tumors
Location: New York NY, Fairfax VA, Sarasota FL, Nashville TN
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07107230

Phase 1, Recruiting

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

for
Malignant Mesothelioma, Metastatic Malignant Solid Tumor,
Location: Philadelphia PA, Cleveland OH, Nashville TN, Denver CO,
Sponsor: InSilico Medicine Hong Kong Limited

Sex: All

Age: 18+

Code: NCT06566079

Phase 1, Phase 2, Recruiting

A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

for
Recurrent or Metastatic Solid Tumors
Location: Charlotte NC, Maumee OH, Atlanta GA, Nashville TN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07015697

Phase 1, Recruiting

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

for
Soft-tissue Sarcoma, Triple Negative Breast Cancer,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT07064018

Phase 1, Phase 2, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: Boston MA, Quebec, Lake Success NY, The Bronx NY,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase 3, Recruiting

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

for
Advanced Solid Tumors
Location: Portland OR
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT06719362

Phase 1, Recruiting

Impact of Daily Oral Cannabis Doses in Patients With Cancer

for
Cancer, Cancers, Pain
Location: Lexington KY
Sponsor: Shanna Babalonis, PhD

Sex: All

Age: 18+

Code: NCT06601218

Phase 1, Recruiting

Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06760754

Recruiting

A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer

for
Solid Tumor Cancer
Location: Richmond Hill NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07117461

Recruiting

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

for
Metastatic Pancreatic Ductal Adenocarcinoma,
Location: Miami FL
Sponsor: Benjamin Spieler

Sex: All

Age: 18+

Code: NCT06843551

Phase 2, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial